Forty-six existing tissue samples (34 out of 46 were BRAF/NRAS mutated) of metastatic malignant melanoma from 21 patients that originate from diagnostic testing undertaken at the Klinikum Kassel from January 2015 to September 2022 were analysed. This evidence concerns the gene NRAS and melanoma.